MAPT and Alzheimer disease: Although the presence of AD was not associated with DAT‐AC or PMWH‐A in the subgroup that underwent both FBB and DAT PET scans (Table S5), future studies are needed to investigate the effect of AD pathologies, including amyloid β or tau burden, on the dopaminergic system and WMHs.